These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 1417382)
21. Long-term mortality and renal outcome in a cohort of 100 patients with lupus nephritis. Faurschou M; Dreyer L; Kamper AL; Starklint H; Jacobsen S Arthritis Care Res (Hoboken); 2010 Jun; 62(6):873-80. PubMed ID: 20191478 [TBL] [Abstract][Full Text] [Related]
22. Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival. Sisó A; Ramos-Casals M; Bové A; Brito-Zerón P; Soria N; Muñoz S; Testi A; Plaza J; Sentís J; Coca A Lupus; 2008 Apr; 17(4):281-8. PubMed ID: 18413408 [TBL] [Abstract][Full Text] [Related]
23. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ]. Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309 [TBL] [Abstract][Full Text] [Related]
24. Prognostic factors in diffuse proliferative lupus nephritis. Abraham MA; Korula A; Jayakrishnan K; John GT; Thomas PP; Jacob CK J Assoc Physicians India; 1999 Sep; 47(9):862-5. PubMed ID: 10778652 [TBL] [Abstract][Full Text] [Related]
26. [Lupus nephritis: retrospective analysis of the course of the disease]. Djukanović L; Pavlović S; Blagojević R; Dimitrijević J; Stojsic T; Ratković M; Kazić K; Lezaić V; Naumović R Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():26-31. PubMed ID: 12583310 [TBL] [Abstract][Full Text] [Related]
27. Primary glomerulonephritis: an update on renal survival and determinants of progression. Moranne O; Watier L; Rossert J; Stengel B; QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806 [TBL] [Abstract][Full Text] [Related]
28. Presentation, prognosis and outcome of IgA nephropathy in Indian adults. Chacko B; John GT; Neelakantan N; Korula A; Balakrishnan N; Kirubakaran MG; Jacob CK Nephrology (Carlton); 2005 Oct; 10(5):496-503. PubMed ID: 16221102 [TBL] [Abstract][Full Text] [Related]
29. Cardiovascular and cerebrovascular morbidity and mortality among women with end-stage renal disease attributable to lupus nephritis. Ward MM Am J Kidney Dis; 2000 Sep; 36(3):516-25. PubMed ID: 10977783 [TBL] [Abstract][Full Text] [Related]
30. Factors associated with refractory renal disease in patients with systemic lupus erythematosus: the role of patient nonadherence. Bruce IN; Gladman DD; Urowitz MB Arthritis Care Res; 2000 Dec; 13(6):406-8. PubMed ID: 14635317 [TBL] [Abstract][Full Text] [Related]
31. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease. Tsui JI; Vittinghoff E; Shlipak MG; Bertenthal D; Inadomi J; Rodriguez RA; O'Hare AM Arch Intern Med; 2007 Jun; 167(12):1271-6. PubMed ID: 17592100 [TBL] [Abstract][Full Text] [Related]
32. Duration of end-stage renal disease and kidney transplant outcome. Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892 [TBL] [Abstract][Full Text] [Related]
33. The long-term outcome of 93 patients with proliferative lupus nephritis. Moroni G; Quaglini S; Gallelli B; Banfi G; Messa P; Ponticelli C Nephrol Dial Transplant; 2007 Sep; 22(9):2531-9. PubMed ID: 17510096 [TBL] [Abstract][Full Text] [Related]
34. Effect of hypertension, diabetes, and smoking on development of renal dysfunction after heart transplantation. Sánchez Lázaro IJ; Almenar Bonet L; Martínez-Dolz L; Moro López J; Agüero Ramón-Llín J; Cano Pérez O; Rueda Soriano J; Buendía Fuentes F; Navarro Manchón J; Raso Raso R; Salvador Sanz A Transplant Proc; 2008 Nov; 40(9):3049-50. PubMed ID: 19010189 [TBL] [Abstract][Full Text] [Related]
35. Hypertension as a marker for later development of end-stage renal failure after lung and heart-lung transplantation: a cohort study. Kunst H; Thompson D; Hodson M J Heart Lung Transplant; 2004 Oct; 23(10):1182-8. PubMed ID: 15477113 [TBL] [Abstract][Full Text] [Related]
36. Prognostic value of renal hemodynamic characteristics in patients with proliferative lupus nephritis. Martens HA; Bijl M; Kallenberg CG Kidney Blood Press Res; 2007; 30(3):175-81. PubMed ID: 17519528 [TBL] [Abstract][Full Text] [Related]
37. The benefit of early treatment with immunosuppressive agents in lupus nephritis. Esdaile JM; Joseph L; MacKenzie T; Kashgarian M; Hayslett JP J Rheumatol; 1994 Nov; 21(11):2046-51. PubMed ID: 7869308 [TBL] [Abstract][Full Text] [Related]
38. Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. Costenbader KH; Desai A; Alarcón GS; Hiraki LT; Shaykevich T; Brookhart MA; Massarotti E; Lu B; Solomon DH; Winkelmayer WC Arthritis Rheum; 2011 Jun; 63(6):1681-8. PubMed ID: 21445962 [TBL] [Abstract][Full Text] [Related]
39. Syndrome of rapid-onset end-stage renal disease: a new unrecognized pattern of CKD progression to ESRD. Onuigbo MA Ren Fail; 2010; 32(8):954-8. PubMed ID: 20722563 [TBL] [Abstract][Full Text] [Related]
40. Interstitial inflammation and long-term renal outcomes in lupus nephritis. Alsuwaida AO Lupus; 2013 Dec; 22(14):1446-54. PubMed ID: 24097970 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]